Jazz Pharmaceuticals PLC at Cowen Health Care Conference Transcript
(technical difficulty) Kim and John, for joining us and making the long trip out. I know it's the 43rd annual -- Bruce, I can't remember when we first got together, but it's been a lot of years. All of a sudden, I was trying to count it up. Why don't we just start off? I know maybe you want to make some opening comments. And then we'll get into Q&A.
Yes, so happy to -- let me start out with the exciting opening comments. We're going to make forward-looking statements. See our risk factors. If I refer to non-GAAP financials, we always have a reconciliation on our website. I'll also point out if you're watching me in the room, I have a tremor in my right hand, that's not nerves. If my left hand starts shaking, I'm nervous. So you can differentiate on that.
I'm joined by 2 colleagues here in front of you. Kim Sablich has been with the company since June 1, 2020, runs our U.S. commercial business, overseen a number of successful launches already during her tenure.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |